Seeking Alpha

Covidien (COV +2.2%) trades higher after announcing the FDA has issued a clearance for the...

Covidien (COV +2.2%) trades higher after announcing the FDA has issued a clearance for the company's SpiderFX, an embolic protection device for the treatment of severely calcified arterial lesions in the lower extremities.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector